Skip to main content

Key messages

Gastro-oesophageal reflux is common in infants. But it is often misdiagnosed and treated unnecessarily with acid suppression therapy (AST).

AST has been shown to have no benefit for infants with gastro-oesophageal reflux or unsettled behaviours. In fact, the latest evidence shows ASTs are associated with an increased risk of gastroenteritis, community-acquired pneumonia, Clostridium Difficile infection, fractures and micronutrient deficiencies and asthma in infants.

Please use our clinical and parent resources to reduce unnecessary prescribing.

In collaboration with The Royal Children’s Hospital and three Victorian public hospitals, we have developed a number of clinician and parent/caregiver resources to reduce unnecessary prescribing of acid suppression therapies (ASTs) in infants.

These resources will help to support your clinical practice to better recognise, respond to and manage infants with gastro-oesophageal reflux, irritability or excessive crying. The resources will also help to ensure you are able to provide the correct information to parents and caregivers, aiding in their ability to make informed decisions about their infant’s care.

The resources centre on a number of key areas:

  • Diagnosis of gastro-oesophageal reflux versus gastro-oesophageal reflux disease
  • Potential harms and benefits associated with the use of ASTs in infants
  • Recommendations on how to cease ASTs in infants
  • Strategies to manage irritability, excessive crying and unsettled behaviours in infants.

Download the resources

SCV endorses The Royal Children’s Hospital clinical practice guidelines for managing gastro-oesophageal reflux and unsettled behaviours in infants.

View the guidelines

Get in touch

Centre of Clinical Excellence - Women and Children
Safer Care Victoria

Page last updated: 09 Mar 2021

Was this content helpful to you?